Tuesday, October 28, 2025

Top 5 This Week

Related Posts

Finding an ADHD Treatment Helped Change the Game for Jay Glazer

- Advertisement -

0:00

- Advertisement -

JAY GLAZER, one of the biggest personalities in sports broadcasting, has built a career around high energy and quick delivery. Whether breaking major stories on live TV or doing exclusive interviews with the brightest stars in professional football, he thrives in big moments. On top of that, he’s become an outspoken mental health advocate championing men’s mental health.

Yet for decades, he struggled with attention-deficit/hyperactivity disorder (ADHD)—a common psychiatric disorder marked by symptoms such as inattention, impulsivity, and hyperactivity. “Imagine being in the middle of a live interview, trying to have a conversation with the person across from you, but your brain is already racing ahead to the next segment,” says Jay, 55. “Instead of responding in real time, I felt scattered, sometimes even cutting people off. I was constantly trying to keep up with my brain.”

- Advertisement -

For Jay, ADHD—which affects approximately 15 million adult Americans—felt like an invisible opponent that followed him from the studio to everyday life. Living with the condition required figuring out how to manage his symptoms without losing his edge.

Playing Without a Playbook

JAY FIRST LEARNED he had ADHD in 1989, during his first year of college. His struggle to sit through lengthy lectures or even attend class at all led to academic trouble, and professors often misunderstood his requests for breaks as excuses. “Back then, most people had no clue what ADHD even was,” he says. “It was a confusing thing to navigate. I had a ton of tough moments in the beginning and it just felt like there wasn’t anything or anyone that could help.”

His doctors initially prescribed him stimulant medication, which helped in some ways but wasn’t the right fit long-term for him. In the meantime, Jay wrestled with his ADHD symptoms, feeling restless, distracted, and weighed down by frustration that no one around him seemed to understand. “Even after being diagnosed with ADHD, I still struggled with it for many, many years,” he says. “I felt like I was really on my own trying to figure it out.”

- Advertisement -

Teamwork at Home

jay glazer and rosie glazer on beach

Supernus

Jay Glazer shares how finding the right ADHD treatment and support system has been a game-changer for him.

WHEN JAY AND his wife, Rosie, first met during the pandemic, she was struck by his commanding presence and contagious energy. But as their relationship deepened, the everyday challenges of his ADHD became more apparent.

“At first, I didn’t know a ton about ADHD—I didn’t even know right away that he had the condition,” Rosie says. “Then I started noticing how easily distracted he was by things like his phone, how often he’d lose track of what I was saying and interrupt me, or how hard it was for him to sit still without fidgeting.”

At times she even felt brushed off, not realizing these behaviors as signs of ADHD. But eventually, they started talking about the challenges Jay was facing—and the toll it was taking on their relationship. “We had to learn to communicate in a way that truly allowed us to hear and understand each other,” Rosie says. That openness laid the groundwork for them to start tackling his ADHD journey together, rather than playing on opposing sides.

Changing the Game

JAY’S TURNING POINT came when he realized that his ADHD was affecting not just him, but his partner, too. “I wanted to listen to Rosie, to be present,” he says. “Wanting to truly be there for her, to show up the way she deserved, was the ‘something’s gotta change’ moment for me.”

With the encouragement of Rosie, friends, and fellow broadcasters he connected with over his condition, Jay spoke to his doctor about treatment options. That conversation led him to QELBREE (viloxazine extended-release capsules), a medication developed by Supernus Pharmaceuticals.

Qelbree® (viloxazine extended-release capsules) is a prescription medicine used to treat ADHD in adults and children 6 years and older. Please click here for full Prescribing Information, including Boxed Warning, and Medication Guide.

IMPORTANT SAFETY INFORMATION

Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

See below for full Important Safety Information.

Jay Glazer is an actual Qelbree patient. Jay and Rosie Glazer are compensated ambassadors. Intended for U.S. Audiences Only.

QELBREE was a good fit for Jay’s lifestyle. It’s a non-stimulant that he could take once each night, which was easier to fit in his hectic schedule. Convenience was another perk: QELBREE is a not a controlled substance and shows no evidence of abuse. It can be conveniently refilled each month without a new prescription and can be available for 90-day refills—ideal for someone who spends so much of the year bouncing between studios and airports.

Rosie played a major role in Jay’s ADHD management, from being a supportive voice of encouragement, to helping him maintain a strong nightly routine. To keep him consistent, she began leaving his medication bottle on the nightstand before bed—a small act that reinforced their teamwork and kept him on track.

IMPORTANT SAFETY INFORMATION

You should not take Qelbree if you or your child:

Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

See below for full Important Safety Information.

Finding His Rhythm

jay glazer and rosie glazer at night

Supernus

After Jay started his once-daily treatments with QELBREE, Rosie noticed a difference in his ADHD symptoms.

THERE WASN’T A single “lightbulb moment” where Jay recognized this was the right treatment for him. Rather, progress continually showed up in small but noticeable ways. “One of the first real signs was just being more present,” Jay says. “I remember having a conversation with Rosie and realizing my mind wasn’t racing a mile a minute. I was actually there, listening, engaged.”

Suddenly, sitting through a movie wasn’t out of the question. “Before, even simple chores felt impossible,” he says. “Once I started treatment, I could stay on task and follow through on projects.”

“QELBREE helped me manage my ADHD symptoms, both at home and in front of the camera,” Jay continued.

The changes have been equally meaningful for Rosie. “Over time it’s been nice to see him manage his ADHD symptoms,” she says. “I’m proud of how open he’s become about ADHD—not just with me, but with his colleagues, friends, family, and through his advocacy raising awareness.”

Coaching Others

TODAY, JAY SPEAKS about ADHD as candidly as he does about sports. “I know many men, including myself, have found it difficult to take mental health seriously and talk about ADHD,” he says. “But having those conversations helps reduce stigma and gives people the chance to learn from one another.”

He now shares his story with fellow broadcasters, coaches, and players, and often discovers that others face similar struggles. “It’s rewarding when you realize you’re not alone, and at least one person understands what you’re going through,” he says.

Jay sees his journey with ADHD as proof that perseverance and openness are catalysts for change. “Starting QELBREE felt like the missing puzzle piece I’d been waiting for to help me manage my ADHD symptoms,” he says, adding this bit of advice for anyone struggling with ADHD symptoms: “Schedule an appointment with your doctor, and explore all treatment options, including non-stimulant QELBREE, and find what works best for you.”

Visit Qelbree.com to see if Qelbree may be a good fit for you.

INDICATION

Qelbree (viloxazine extended-release capsules) is a prescription medicine used to treat ADHD in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION

Qelbree® may increase suicidal thoughts and actions in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide, including Boxed Warning.

QBE.2025-0269

Read More

- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular Articles